Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting

Autor: F Reinhuber, B Wilde, U Steller, J Knauss, C Sous-Kulke, E. Bernd Ringelstein, Franziska Wigbers, Wolfram Ziegler, F-J Ferneding, B Gröne, Jörg B. Schulz, K Schulz, W Hofmann, K Krakow, Indra Hempen, Ralf Glindemann, W Schupp, Klaus-Jürgen Schlenck, C Berghoff, Walter Huber, Stefanie Abel, E Schillikowski, F Hamzei, Agnes Flöel, Klaus Willmes, Jonathan List, E König, H Hoffmann, Roman Rocker, K Halm, Frank Regenbrecht, Frank Domahs, S-B Schipke, K Billo, G. Pfeiffer, Christina Rühmkorf, A Oertel, M Bley, O'n Som, A Kartmann, Ana-Claire Meyer, Ernst de Langen, S Runge, Georg Goldenberg, Annette Baumgaertner, F Müller, R Sudhoff, S Krüger, Tanja Grewe, S Bamborschke, D Bätz, I Maser, S Miethe, Peter Martus, Luise Springer, Caterina Breitenstein, Hellmuth Obrig, Stefan Knecht, R Baake, T Keck, Karl Georg Haeusler, Arno Villringer, V Middeldorf, G Klingenberg, M Jöbges, Marion Thomas, Cornelius J. Werner

Publikováno v: Lancet (London, England). 389(10078)

Summary Background Treatment guidelines for aphasia recommend intensive speech and language therapy for chronic (≥6 months) aphasia after stroke, but large-scale, class 1 randomised controlled trials on treatment effectiveness are scarce. We aimed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b46a8726ffd0acdb8569bc4b9c1ee1eb
https://pubmed.ncbi.nlm.nih.gov/28721876